Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease—Paving the Way for Vaccine Development

The emergence of the COVID-19 outbreak at the end of 2019, caused by the novel coronavirus SARS-CoV-2, has, to date, led to over 13.6 million infections and nearly 600,000 deaths. Consequently, there is an urgent need to better understand the molecular factors triggering immune defense against the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranga, Vipin, Niemelä, Erik, Tamirat, Mahlet Z., Eriksson, John E., Airenne, Tomi T., Johnson, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564651/
https://www.ncbi.nlm.nih.gov/pubmed/32717854
http://dx.doi.org/10.3390/vaccines8030408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564651/
https://www.ncbi.nlm.nih.gov/pubmed/32717854
http://dx.doi.org/10.3390/vaccines8030408

Ejemplares similares